Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 814


Bimekizumab for the Treatment of Psoriatic Disease.

Natsis NE, Gottlieb AB.

Expert Opin Biol Ther. 2018 Oct 18. doi: 10.1080/14712598.2018.1538351. [Epub ahead of print]


Comparison of Different Remission and Low Disease Definitions in Psoriatic Arthritis and Evaluation of Their Prognostic Value.

Coates LC, Gottlieb AB, Merola JF, Boone C, Szumski A, Chhabra A.

J Rheumatol. 2018 Oct 15. pii: jrheum.180249. doi: 10.3899/jrheum.180249. [Epub ahead of print]


Job Negotiations in Academic Medicine: Building a Competency-Based Roadmap for Residents and Fellows.

Berman RA, Gottlieb AS.

J Gen Intern Med. 2018 Oct 1. doi: 10.1007/s11606-018-4632-2. [Epub ahead of print]


A Provider Global Assessment Quality Measure for Clinical Practice for Inflammatory Skin Disorders.

International Dermatology Outcome Measures and the American Academy of Dermatology, Gottlieb A, Salame N, Armstrong AW, Merola JF, Parra S, Takeshita J, Chen SC, Latella J, Van Beek M.

J Am Acad Dermatol. 2018 Sep 19. pii: S0190-9622(18)32598-2. doi: 10.1016/j.jaad.2018.09.017. [Epub ahead of print]


Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trials.

Blauvelt A, Reich K, Lebwohl M, Burge D, Arendt C, Peterson L, Drew J, Rolleri R, Gottlieb AB.

J Eur Acad Dermatol Venereol. 2018 Sep 22. doi: 10.1111/jdv.15258. [Epub ahead of print]


How to Define Acute Liver Failure Patients with Pre-Existing Liver Disease without Signs of Cirrhosis.

Gottlieb A, Kottmann M, Manka P, Bedreli S, Hadem J, Bechmann L, Sowa JP, Gerken G, Canbay A.

Dig Dis. 2018 Sep 18:1-8. doi: 10.1159/000492869. [Epub ahead of print]


Benefit-risk profile of tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: pooled analysis across six clinical trials.

Strober BE, Gottlieb AB, van de Kerkhof PCM, Puig L, Bachelez H, Chouela E, Imafuku S, Thaçi D, Tan H, Valdez H, Gupta P, Kaur M, Frajzyngier V, Wolk R.

Br J Dermatol. 2018 Sep 6. doi: 10.1111/bjd.17149. [Epub ahead of print]


Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative.

Perez-Chada LM, Cohen JM, Gottlieb AB, Duffin KC, Garg A, Latella J, Armstrong AW, Ogdie A, Merola JF.

Arch Dermatol Res. 2018 Nov;310(9):701-710. doi: 10.1007/s00403-018-1855-3. Epub 2018 Aug 25.


Safety of Ixekizumab in Patients with Psoriatic Arthritis: Results from a Pooled Analysis of Three Clinical Trials.

Mease P, Roussou E, Burmester GR, Goupille P, Gottlieb A, Moriarty SR, Benichou O, Adams DH, Xu W, Nash P.

Arthritis Care Res (Hoboken). 2018 Aug 29. doi: 10.1002/acr.23738. [Epub ahead of print]


Personality, environmental stressors, and diarrhea in Rhesus macaques: An interactionist perspective.

Gottlieb DH, Del Rosso L, Sheikhi F, Gottlieb A, McCowan B, Capitanio JP.

Am J Primatol. 2018 Aug 28:e22908. doi: 10.1002/ajp.22908. [Epub ahead of print]


Are Your Patients Satisfied? A Systematic Review of Treatment Satisfaction Measures in Psoriasis.

Salame N, Perez-Chada LM, Singh S, Callis Duffin K, Garg A, Gottlieb AB, Latella J, Merola JF, Armstrong AW.

Dermatology. 2018 Aug 17:1-9. doi: 10.1159/000490413. [Epub ahead of print]


Reducing the Incidence of Substance Use Disorders in Anesthesiology Residents: 13 Years of Comprehensive Urine Drug Screening.

Fitzsimons MG, Baker K, Malhotra R, Gottlieb A, Lowenstein E, Zapol WM.

Anesthesiology. 2018 Oct;129(4):821-828. doi: 10.1097/ALN.0000000000002348.


Bringing the Real World Into Developmental Science: A Commentary on Weber, Fernald, and Diop (2017).

Morelli G, Bard K, Chaudhary N, Gottlieb A, Keller H, Murray M, Quinn N, Rosabal-Coto M, Scheidecker G, Takada A, Vicedo M.

Child Dev. 2018 Jul 10. doi: 10.1111/cdev.13115. [Epub ahead of print]


Rationale and Models for Career Advancement Sponsorship in Academic Medicine: The Time Is Here; the Time Is Now.

Gottlieb AS, Travis EL.

Acad Med. 2018 Jul 3. doi: 10.1097/ACM.0000000000002342. [Epub ahead of print]


Virtual reality-based cognitive-motor training for middle-aged adults at high Alzheimer's disease risk: A randomized controlled trial.

Doniger GM, Beeri MS, Bahar-Fuchs A, Gottlieb A, Tkachov A, Kenan H, Livny A, Bahat Y, Sharon H, Ben-Gal O, Cohen M, Zeilig G, Plotnik M.

Alzheimers Dement (N Y). 2018 Mar 27;4:118-129. doi: 10.1016/j.trci.2018.02.005. eCollection 2018.


Ixekizumab improves patient-reported outcomes up to 52 weeks in bDMARD-naïve patients with active psoriatic arthritis (SPIRIT-P1).

Gottlieb AB, Strand V, Kishimoto M, Mease P, Thaçi D, Birt J, Lee CH, Shuler CL, Lin CY, Gladman DD.

Rheumatology (Oxford). 2018 Oct 1;57(10):1777-1788. doi: 10.1093/rheumatology/key161.


Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies.

Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, Gottlieb AB, Gisondi P, Wu JJ, Thyssen JP, Egeberg A.

J Am Acad Dermatol. 2018 Jun 19. pii: S0190-9622(18)32149-2. doi: 10.1016/j.jaad.2018.06.027. [Epub ahead of print] Review.


Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review.

Ford AR, Siegel M, Bagel J, Cordoro KM, Garg A, Gottlieb A, Green LJ, Gudjonsson JE, Koo J, Lebwohl M, Liao W, Mandelin AM 2nd, Markenson JA, Mehta N, Merola JF, Prussick R, Ryan C, Schwartzman S, Siegel EL, Van Voorhees AS, Wu JJ, Armstrong AW.

JAMA Dermatol. 2018 Aug 1;154(8):934-950. doi: 10.1001/jamadermatol.2018.1412.


Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study.

Deodhar A, Gottlieb AB, Boehncke WH, Dong B, Wang Y, Zhuang Y, Barchuk W, Xu XL, Hsia EC; CNTO1959PSA2001 Study Group.

Lancet. 2018 Jun 2;391(10136):2213-2224. doi: 10.1016/S0140-6736(18)30952-8. Epub 2018 Jun 1.


Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials.

Callis Duffin K, Merola JF, Christensen R, Latella J, Garg A, Gottlieb AB, Armstrong AW.

JAMA Dermatol. 2018 Oct 1;154(10):1137-1144. doi: 10.1001/jamadermatol.2018.1165.


Report of the Skin Research Working Groups from the GRAPPA 2017 Annual Meeting.

Gottlieb AB, Coates LC, van Mens LJJ, Armstrong AW, Merola JF.

J Rheumatol Suppl. 2018 Jun;94:40-43. doi: 10.3899/jrheum.180137.


Prologue: 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

Helliwell PS, Gladman DD, Gottlieb AB.

J Rheumatol Suppl. 2018 Jun;94:1-3. doi: 10.3899/jrheum.180129.


Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis.

Ryan C, Menter A, Guenther L, Blauvelt A, Bissonnette R, Meeuwis K, Sullivan J, Cather JC, Yosipovitch G, Gottlieb AB, Merola JF, Callis Duffin K, Fretzin S, Osuntokun OO, Burge R, Naegeli AN, Yang FE, Lin CY, Todd K, Potts Bleakman A; IXORA-Q Study Group.

Br J Dermatol. 2018 Oct;179(4):844-852. doi: 10.1111/bjd.16736. Epub 2018 Jul 22.


The Presence and Severity of Nonalcoholic Steatohepatitis Is Associated with Specific Changes in Circulating Bile Acids.

Gottlieb A, Bechmann L, Canbay A.

Ann Hepatol. 2018 May-June;17(3):340-341. doi: 10.5604/01.3001.0011.7378. Epub 2018 Apr 9.


Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2).

Gottlieb AB, Blauvelt A, Thaçi D, Leonardi CL, Poulin Y, Drew J, Peterson L, Arendt C, Burge D, Reich K.

J Am Acad Dermatol. 2018 Aug;79(2):302-314.e6. doi: 10.1016/j.jaad.2018.04.012. Epub 2018 Apr 13.


A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process.

Thorlacius L, Ingram JR, Villumsen B, Esmann S, Kirby JS, Gottlieb AB, Merola JF, Dellavalle R, Nielsen SM, Christensen R, Garg A, Jemec GBE; HIdradenitis SuppuraTiva cORe outcomes set International Collaboration (HISTORIC).

Br J Dermatol. 2018 Sep;179(3):642-650. doi: 10.1111/bjd.16672. Epub 2018 Jul 5.


Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial.

Papp KA, Merola JF, Gottlieb AB, Griffiths CEM, Cross N, Peterson L, Cioffi C, Blauvelt A.

J Am Acad Dermatol. 2018 Aug;79(2):277-286.e10. doi: 10.1016/j.jaad.2018.03.037. Epub 2018 Mar 30.


Evaluation of sPGA × BSA as an Outcome Measure and Treatment Target for Clinical Practice.

Merola JF, Amato DA, See K, Burge R, Mallinckrodt C, Ojeh CK, Gottlieb A.

J Invest Dermatol. 2018 Sep;138(9):1955-1961. doi: 10.1016/j.jid.2018.01.041. Epub 2018 Mar 22.


Effect of psoriatic arthritis on ixekizumab clinical outcomes in moderate-to-severe psoriasis patients: A post hoc analysis.

Gottlieb AB, Papp KA, Birbara CA, Shuler CL, Burge R, Erickson J, Kerr L, Mease PJ.

J Am Acad Dermatol. 2018 Sep;79(3):593-595. doi: 10.1016/j.jaad.2018.03.008. Epub 2018 Mar 17. No abstract available.


4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis.

van der Heijde D, Deodhar A, FitzGerald O, Fleischmann R, Gladman D, Gottlieb AB, Hoepken B, Bauer L, Irvin-Sellers O, Khraishi M, Peterson L, Turkiewicz A, Wollenhaupt J, Mease PJ.

RMD Open. 2018 Mar 14;4(1):e000582. doi: 10.1136/rmdopen-2017-000582. eCollection 2018. Erratum in: RMD Open. 2018 Mar 26;4(1):.


Fall incidence and associated risk factors among people with a lower limb amputation during various stages of recovery - a systematic review.

Steinberg N, Gottlieb A, Siev-Ner I, Plotnik M.

Disabil Rehabil. 2018 Mar 14:1-10. doi: 10.1080/09638288.2018.1449258. [Epub ahead of print]


Improvement in itch and other psoriasis symptoms with brodalumab in phase 3 randomized controlled trials.

Gottlieb AB, Gordon K, Hsu S, Elewski B, Eichenfield LF, Kircik L, Rastogi S, Pillai R, Israel R.

J Eur Acad Dermatol Venereol. 2018 Mar 6. doi: 10.1111/jdv.14913. [Epub ahead of print]


Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3.

Papp KA, Gordon KB, Langley RG, Lebwohl MG, Gottlieb AB, Rastogi S, Pillai R, Israel RJ.

Br J Dermatol. 2018 Aug;179(2):320-328. doi: 10.1111/bjd.16464. Epub 2018 May 23.


The Myth of Universal Sensitive Responsiveness: Comment on Mesman et al. (2017).

Keller H, Bard K, Morelli G, Chaudhary N, Vicedo M, Rosabal-Coto M, Scheidecker G, Murray M, Gottlieb A.

Child Dev. 2018 Sep;89(5):1921-1928. doi: 10.1111/cdev.13031. Epub 2018 Jan 23.


Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation.

Whitlock SM, Enos CW, Armstrong AW, Gottlieb A, Langley RG, Lebwohl M, Merola JF, Ryan C, Siegel MP, Weinberg JM, Wu JJ, Van Voorhees AS.

J Am Acad Dermatol. 2018 Feb;78(2):383-394. doi: 10.1016/j.jaad.2017.06.043. Review.


Ixekizumab efficacy and safety with and without concomitant conventional disease-modifying antirheumatic drugs (cDMARDs) in biologic DMARD (bDMARD)-naïve patients with active psoriatic arthritis (PsA): results from SPIRIT-P1.

Coates LC, Kishimoto M, Gottlieb A, Shuler CL, Lin CY, Lee CH, Mease PJ.

RMD Open. 2017 Dec 22;3(2):e000567. doi: 10.1136/rmdopen-2017-000567. eCollection 2017.


Estimating the effects of second-line therapy for type 2 diabetes mellitus: retrospective cohort study.

Gottlieb A, Yanover C, Cahan A, Goldschmidt Y.

BMJ Open Diabetes Res Care. 2017 Nov 30;5(1):e000435. doi: 10.1136/bmjdrc-2017-000435. eCollection 2017.


The New HIT: Human Health Information Technology.

Leung TI, Goldstein MK, Musen MA, Cronkite R, Chen JH, Gottlieb A, Leitersdorf E.

Stud Health Technol Inform. 2017;245:768-772.


Cardamom angel.

Gottlieb A.

Med J Aust. 2017 Dec 11;207(11):479. No abstract available.


A precise measurement of the magnetic field in the corona of the black hole binary V404 Cygni.

Dallilar Y, Eikenberry SS, Garner A, Stelter RD, Gottlieb A, Gandhi P, Casella P, Dhillon VS, Marsh TR, Littlefair SP, Hardy L, Fender R, Mooley K, Walton DJ, Fuerst F, Bachetti M, Castro-Tirado AJ, Charcos M, Edwards ML, Lasso-Cabrera NM, Marin-Franch A, Raines SN, Ackley K, Bennett JG, Cenarro AJ, Chinn B, Donoso HV, Frommeyer R, Hanna K, Herlevich MD, Julian J, Miller P, Mullin S, Murphey CH, Packham C, Varosi F, Vega C, Warner C, Ramaprakash AN, Burse M, Punnadi S, Chordia P, Gerarts A, de Paz Martín H, Calero MM, Scarpa R, Acosta SF, Hernández Sánchez WM, Siegel B, Pérez FF, Viera Martín HD, Rodríguez Losada JA, Nuñez A, Tejero Á, Martín González CE, Rodríguez CC, Molgó J, Rodriguez JE, Cáceres JIF, Rodríguez García LA, Lopez MH, Dominguez R, Gaggstatter T, Lavers AC, Geier S, Pessev P, Sarajedini A.

Science. 2017 Dec 8;358(6368):1299-1302. doi: 10.1126/science.aan0249. Erratum in: Science. 2018 Apr 20;360(6386):.


The Development of the Genital Psoriasis Sexual Frequency Questionnaire (GenPs-SFQ) to Assess the Impact of Genital Psoriasis on Sexual Health.

Gottlieb AB, Kirby B, Ryan C, Naegeli AN, Burge R, Potts Bleakman A, Anatchkova MD, Cather J.

Dermatol Ther (Heidelb). 2018 Mar;8(1):33-44. doi: 10.1007/s13555-017-0212-3. Epub 2017 Dec 4.


The Development of a Patient-Reported Outcome Measure for Assessment of Genital Psoriasis Symptoms: The Genital Psoriasis Symptoms Scale (GPSS).

Gottlieb AB, Kirby B, Ryan C, Naegeli AN, Burge R, Potts Bleakman A, Anatchkova MD, Yosipovitch G.

Dermatol Ther (Heidelb). 2018 Mar;8(1):45-56. doi: 10.1007/s13555-017-0213-2. Epub 2017 Dec 4.


Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.

Coates LC, FitzGerald O, Merola JF, Smolen J, van Mens LJJ, Bertheussen H, Boehncke WH, Callis Duffin K, Campbell W, de Wit M, Gladman D, Gottlieb A, James J, Kavanaugh A, Kristensen LE, Kvien TK, Luger T, McHugh N, Mease P, Nash P, Ogdie A, Rosen CF, Strand V, Tillett W, Veale DJ, Helliwell PS.

Arthritis Rheumatol. 2018 Mar;70(3):345-355. doi: 10.1002/art.40391. Epub 2018 Feb 6.


Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans.

Gottlieb A, Daneshjou R, DeGorter M, Bourgeois S, Svensson PJ, Wadelius M, Deloukas P, Montgomery SB, Altman RB.

Genome Med. 2017 Nov 24;9(1):98. doi: 10.1186/s13073-017-0495-0.


Are cytological parameters of maize landraces (Zea mays ssp. mays) adapted along an altitudinal cline?

Fourastié MF, Gottlieb AM, Poggio L, González GE.

J Plant Res. 2018 Mar;131(2):285-296. doi: 10.1007/s10265-017-0996-3. Epub 2017 Nov 24.


Integral Phylogenomic Approach over Ilex L. Species from Southern South America.

Cascales J, Bracco M, Garberoglio MJ, Poggio L, Gottlieb AM.

Life (Basel). 2017 Nov 22;7(4). pii: E47. doi: 10.3390/life7040047.


Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA × BSA) composite tool: An analysis of apremilast phase 3 ESTEEM data.

Gottlieb AB, Merola JF, Chen R, Levi E, Duffin KC.

J Am Acad Dermatol. 2017 Dec;77(6):1178-1180. doi: 10.1016/j.jaad.2017.06.162. No abstract available.


Supplemental Content

Loading ...
Support Center